首页> 外文OA文献 >PCN68 COST-EFFECTIVENESS OF PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM VERSUS FILGRASTIM FOR THE PREVENTION OF FEBRILE NEUTROPENIA IN NON-HODGKIN LYMPHOMA AND STAGE II BREAST CANCER PATIENTS IN GERMANY

【2h】

PCN68 COST-EFFECTIVENESS OF PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM VERSUS FILGRASTIM FOR THE PREVENTION OF FEBRILE NEUTROPENIA IN NON-HODGKIN LYMPHOMA AND STAGE II BREAST CANCER PATIENTS IN GERMANY

机译：PCN68预防与预防非霍奇金淋巴瘤和Ⅱ期乳腺癌患者中性纤维少见的原发性前列腺炎联合PEGFILGRASTIM VS FILGRASTIM的成本效益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Taylor DC; Ozer-Deniz S; Hill G; Skornicki M; Danel A; Kunz E;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Pegfilgrastim Versus Filgrastim for Primary Prophylaxis of Febrile Neutropenia in Patients with non-Hodgkin’s Lymphoma: A Cost-Effectiveness Study [J] . Ramin Ravangard, Najme Bordbar, Khosro Keshavarz, Asian Pacific Journal of Cancer Prevention . 2017,第10期

机译：非霍奇金淋巴瘤患者的培格非司亭和非格司亭对发热性中性粒细胞减少症的一级预防：成本-效果研究
2. Pegfilgrastim vs filgrastim in primary prophylaxis of febrile neutropenia in patients with breast cancer after chemotherapy: a cost-effectiveness analysis for Germany [J] . Sehouli J, Goertz A, Steinle T, DMW: Deutsche Medizinische Wochenschrift . 2010,第9期

机译：Pegfilgrastim vs filgrastim初步预防化疗后乳腺癌患者发热性中性粒细胞减少症：德国的成本-效果分析
3. Cost-effectiveness of filgrastim and pegfilgrastim as primary prophylaxis against febrile neutropenia in lymphoma patients [J] . LathiaN., IsogaiP.K., AngelisC.D., Journal of the National Cancer Institute . 2013,第15期

机译：非格司亭和培非司亭用于预防淋巴瘤患者发热性中性粒细胞减少症的成本效益
4. Optimal Fuzzy Dosage Programming for Patients Suffering from Breast Cancer in Stage IIB [C] . Hamid Khaloozadeh, Fahimeh Miri Cairo International Biomedical Engineering Conference . 2008

机译：IIB舞台乳腺癌患者的最佳模糊剂量编程
5. Effects of primary prophylaxis of neutropenia on outcomes, utilization and expenditures for elderly breast cancer patients receiving chemotherapy. [D] . Rajan, Suja S. 2009

机译：一级预防中性粒细胞减少对老年接受化疗的乳腺癌患者的结局，利用和支出的影响。
6. Pegfilgrastim Versus Filgrastim for Primary Prophylaxis of Febrile Neutropenia in Patients with non-Hodgkin’s Lymphoma: A Cost-Effectiveness Study [O] . Ramin Ravangard, Najme Bordbar, Khosro Keshavarz, 2017

机译：非霍奇金淋巴瘤患者的培格非司亭和非格司亭对发热性中性粒细胞减少症的初步预防：一项成本效果研究
7. PCN14 CLINICAL CONSEQUENCES OF PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM VERSUS FILGRASTIM FOR THE PREVENTION OF FEBRILE NEUTROPENIA IN NON-HODGKIN LYMPHOMA AND STAGE II BREAST CANCER PATIENTS IN GERMANY [O] . Ozer-Deniz S, Taylor DC, Hill G, 2010

机译：预防原发性前列腺炎与PEGFILGRASTIM VS FILGRASTIM在德国非霍奇金淋巴瘤和II期乳腺癌患者中预防神经性中枢神经减少的临床后果

PCN68 COST-EFFECTIVENESS OF PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM VERSUS FILGRASTIM FOR THE PREVENTION OF FEBRILE NEUTROPENIA IN NON-HODGKIN LYMPHOMA AND STAGE II BREAST CANCER PATIENTS IN GERMANY

著录项

引文网络

相似文献

相关主题

期刊订阅